Online citations, reference lists, and bibliographies.
← Back to Search

Multiple Drug-resistant Human KB Carcinoma Cells Independently Selected For High-level Resistance To Colchicine, Adriamycin, Or Vinblastine Show Changes In Expression Of Specific Proteins.

D. Shen, C. Cardarelli, J. Hwang, M. Cornwell, N. Richert, S. Ishii, I. Pastan, M. Gottesman
Published 1986 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
We have established four cell lines derived from the human KB carcinoma cell line which express high-level multiple drug resistance. One of these lines was selected for resistance to colchicine, one was selected for resistance to colchicine in the presence of the tumor promoter, mezerein, one for resistance to vinblastine, and one for resistance to adriamycin. All of these cell lines are cross-resistant to the other selective agents. The development of multidrug resistance in these cultured human carcinoma cells is associated with a limited number of specific protein alterations revealed by high resolution two-dimensional gel electrophoresis and Western blot analysis. These protein alterations in multidrug-resistant lines include the decreased prevalence of members of a family of proteins of molecular mass 70,000 to 80,000 daltons, pI 4.8-5.0, the increased synthesis of a protein of molecular mass 21,000 daltons, pI 5.0, in the colchicine-resistant cell lines only, and the increased expression of a 170,000-dalton protein in membrane preparations from all of the resistant cells. The loss of the 70,000- to 80,000-dalton proteins in the multidrug-resistant lines, which can also be demonstrated by immunoprecipitation of these proteins with specific antisera, is associated with a loss of translatable mRNA for these proteins. These studies suggest that only a limited number of protein changes occur in multidrug-resistant cell lines.



This paper is referenced by
10.3390/ijms22179440
The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Chung-Pu Wu (2021)
10.3390/cancers13010154
Relation of Metal-Binding Property and Selective Toxicity of 8-Hydroxyquinoline Derived Mannich Bases Targeting Multidrug Resistant Cancer Cells
V. Pape (2021)
10.1134/S1990519X21010041
Short-Term Exposure of RJK Cells with Multiple Drug Resistance to Polyallylaminane Destabilizes Their Karyotype Structure
T. Grinchuk (2021)
10.1007/978-1-0716-1130-2_19
Detection of TNF-α Protein in Extracellular Vesicles Derived from Tumor Cells by Western Blotting.
T. Berguetti (2021)
10.1101/2021.07.20.453061
Crystal structures of taxane-tubulin complexes: Implications for the mechanism of microtubule stabilization by Taxol
A. Prota (2021)
10.1016/j.bcp.2020.114137
Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines.
Chung-Pu Wu (2020)
10.3390/cancers12051117
Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
Edina Karai (2020)
10.3390/cells8050500
TNF-α Modulates P-Glycoprotein Expression and Contributes to Cellular Proliferation via Extracellular Vesicles
Tandressa S Berguetti (2019)
10.1158/0008-5472.CAN-19-1407
Unshielding multidrug resistant cancer through selective iron depletion of P-glycoprotein expressing cells.
Mihály Cserepes (2019)
10.1016/j.isci.2019.10.003
Structural Basis of Colchicine-Site targeting Acylhydrazones active against Multidrug-Resistant Acute Lymphoblastic Leukemia
N. M. Cury (2019)
Biotechnology and Bioengineering
Kasama Srirussamee (2019)
10.1016/j.canlet.2019.01.010
Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.
Yanhua Chen (2019)
10.1002/ddr.21628
Substituted chloroacetamides as potential cancer stem cell inhibitors: Synthesis and biological evaluation
Komal N Padhariya (2019)
10.1002/bit.27204
Engineered Fn3 protein has targeted therapeutic effect on mesothelin‐expressing cancer cells and increases tumor cell sensitivity to chemotherapy
Allison R. Sirois (2019)
10.1016/j.ejmech.2018.10.001
The use of proteomic technologies to study molecular mechanisms of multidrug resistance in cancer.
Yi Cao (2019)
10.1038/s41598-018-24114-7
Author Correction: Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Safia Manzoor (2018)
10.1038/s41598-018-21642-0
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Safia Manzoor (2018)
10.1074/jbc.M116.772699
Tumor stressors induce two mechanisms of intracellular P-glycoprotein–mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones
Lina Al-Akra (2018)
10.25911/5c6e71e068eb8
Bioenergetic coupling in P-glycoprotein: determining the relative position, topography and role of transmembrane helices six and twelve
Carey Hulyer (2018)
10.18632/oncotarget.25432
Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins
Daniela Heilos (2018)
10.1039/c8dt03360a
N,N-Dialkylbenzimidazol-2-ylidene platinum complexes - effects of alkyl residues and ancillary cis-ligands on anticancer activity.
Tobias Rehm (2018)
10.1016/j.jconrel.2018.07.015
Modular approach for theranostic polymer conjugates with activatable fluorescence: Impact of linker design on the stimuli‐induced release of doxorubicin
G. Nagel (2018)
Acquired Drug Resistance and Multidrug Resistance Gene ( MDRI ) Expression in the KB Carcinoma Cell Line Xenotransplanted in Nude
M. Yoshiyuki (2018)
10.1371/journal.pone.0197029
Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding
Allison R. Sirois (2018)
10.3390/ph10030072
Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization
K. Siwowska (2017)
10.1016/j.ejmech.2017.02.022
Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
M. Murahari (2017)
10.1016/B978-0-323-52725-5.00008-3
Chapter 8 – Nanoparticle System for Anticancer Drug Delivery: Targeting to Overcome Multidrug Resistance
M. Safhi (2017)
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT 3-Dependent NF-κB and HSP 27 / p 38 / AKT Pathways and by Inhibiting ABCB 1 Jonathan
T. Sims (2017)
10.1186/s12943-017-0593-z
Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy
Guifa Xi (2017)
10.1002/cmdc.201700225
Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters
Balázs Dankó (2017)
The role of ABC transporters and inflammation in drug-resistant epilepsy
Lora Deuitch Weidner (2017)
10.1016/j.ejmech.2017.04.025
Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Gao-Feng Zha (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar